Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Porcine circovirus type 2 Cap protein and thymosin alpha1 fusion protein and application

A porcine circovirus and fusion protein technology, which is applied in porcine circovirus type 2 Cap protein and thymosin α1 fusion protein and its application field, can solve the problems of limited application and promotion, short half-life, high price, etc., and achieve efficient immune response, Good effect on immunogenicity

Active Publication Date: 2012-12-19
QINGDAO VLAND BIOTECH INC +1
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Although thymosin αl has broad application prospects, because its gene is too short, it is difficult to use genetic engineering methods to achieve direct expression, so most of them are chemically synthesized products at present, and the price is relatively expensive. In addition, due to the very small molecular weight, the half-life in vivo is very short. Short, app promotion is limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porcine circovirus type 2 Cap protein and thymosin alpha1 fusion protein and application
  • Porcine circovirus type 2 Cap protein and thymosin alpha1 fusion protein and application
  • Porcine circovirus type 2 Cap protein and thymosin alpha1 fusion protein and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013] The invention relates to a fusion protein composed of porcine circovirus type 2 Cap protein and thymosin α1. Wherein the 131 amino acid fragments of the 3' end of porcine circovirus type 2 Cap protein and the 28 amino acid sequences of thymosin α1 are connected through the Lingker sequence GSGGG, which has the amino acid sequence of SEQ ID NO: 1 and the sequence of SEQ ID NO : The nucleotide sequence of 2. The fusion protein can be prepared by gene recombination methods well known to those skilled in the art.

[0014] The fusion protein composed of recombinantly prepared porcine circovirus type 2 Cap protein and thymosin α1 is emulsified with white oil adjuvant to make porcine circovirus type 2 genetically engineered sub-vaccine. The properties, sterility test, and safety test were all qualified according to the inspection method of the Veterinary Biological Products Regulations. Then the prepared vaccine is immunized to PCV2 negative weaned piglets, and the result sh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a porcine circovirus type 2 Cap protein, thymosin alpha1 fusion protein and an application, and an amino acid sequence of the fusion protein is shown as SEQ ID NO:1. The fusion protein can be used for preparing porcine circovirus type 2 subunit vaccine. The screened porcine circovirus type 2 Cap protein and a thymosin alpha1 gene having immunological enhancement effect are connected through a Lingker sequence to obtain the fusion protein. The genetic engineering subunit vaccine of the invention has good immunogenicity, and the immune response of piglet can be caused with high efficiency.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to a fusion protein of porcine circovirus type 2 Cap protein and thymosin α1 and its application. Background technique [0002] Porcine Circovirus type 2 (PCV2) is the causative agent of Postweaning multsystemic wasting syndrome (PMWS), which causes progressive emaciation, cough, dyspnea, diarrhea, and pale skin in weaned piglets Or symptoms such as yellow staining, swollen lymph nodes, and gray-white edema of the kidneys. At the same time, the disease can also cause a certain degree of immunosuppression, which can easily cause secondary or concurrent infections of other diseases. Since clinical porcine circovirus was first discovered in Canada in 1991, the disease has caused huge economic losses to the swine industry all over the world. The Cap protein encoded by the ORF2 gene of porcine circovirus type 2 is the main structural protein of PCV2, which can self-assemble into viral part...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00A61K39/12A61K39/39A61P31/20
Inventor 王宏华凌红丽于春梅王雷徐丽丽
Owner QINGDAO VLAND BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products